enGene Therapeutics Inc. (ENGN): SCHEDULE 13G filed May 13, 2026

Form type

SCHEDULE 13G

Filing date

May 13, 2026

Accession number

0001373604-26-000041

Filer

enGene Therapeutics Inc. (CIK 1980845)